The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts
Authors:
- Sabine MerlSMSabine Merl
- Adnan KastratiAKAdnan Kastrati
- Anna WieczorekAWAnna Wieczorek
- Marc VorpahlMVMarc Vorpahl
- Raimund MannholdRMRaimund Mannhold
- Michael VogeserMVMichael Vogeser
- Jörg HausleiterJHJörg Hausleiter
- Michael JonerMJMichael Joner
- Albert SchömigASAlbert Schömig
- Rainer WesselyRWRainer Wessely
- 1 February 2009
- journal article
- Published by Elsevier in Biomaterials
- Vol. 30 (4) , 632-637
Abstract
No abstract availableKeywords
Funding Information
- Bayerische Forschungsstiftung (504/02, 668/05)
This publication has 32 references indexed in Scilit:
- Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimusThrombosis and Haemostasis, 2007
- Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelializationAtherosclerosis, 2006
- Role of probucol in inhibiting intimal hyperplasia after coronary stent implantation: A randomized studyAmerican Heart Journal, 2006
- Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavengingJournal of Experimental Medicine, 2006
- Coronary-Artery StentsNew England Journal of Medicine, 2006
- Sirolimus and Paclitaxel on Polymer-Based Drug-Eluting StentsJACC, 2006
- Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Reduction of Late Lumen LossCirculation, 2006
- Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coatingEuropean Heart Journal, 2005
- Inhibition of Neointima Formation by a Novel Drug-Eluting Stent System That Allows for Dose-Adjustable, Multiple, and On-Site Stent CoatingArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine modelJACC, 1992